39th EFI/BSHI Conference 2026

Join BIOTYPE at the EFI Congress in Edinburgh!

We will be showcasing our comprehensive chimerism portfolio. Our assays are designed to provide flexible and highly sensitive engraftment monitoring following allogeneic hematopoietic stem cell transplantation (HSCT):

Multiplex PCR & qPCR workflows‍

Mentype® Chimera®, DIPscreen, and DIPquant assays enable rapid routine chimerism monitoring. Combined with our proprietary ChimerisMonitor software, they provide more than just data: the software provides clear trend analyses that intuitively visualize chimerism dynamics. This allows engraftment trends to be captured at a glance, ensuring robust monitoring when precision is paramount.

Digital PCR (dPCR)‍

When maximum sensitivity is required, Mentype® DigitalScreen, and DigitalQuant kits provide absolute quantification without the need for calibration curves. They detect chimerism as little as ≤ 0.1 %, offering a powerful tool for surveilling subtle chimerism changes across multiple dPCR systems.

‍

Whether your focus is on routine monitoring or high-sensitivity relapse detection, Stefan Albrecht-Lienau, Dr. Felix Zörgiebel, and Marina Levichkova are ready to discuss the best fit for your laboratory.  

Meet us at Booth 18 to explore BIOTYPE’s extensive chimerism portfolio!